MBX Biosciences (MBX) Depreciation & Amortization (CF) (2023 - 2026)
MBX Biosciences (MBX) reported Depreciation & Amortization (CF) of $100,000 for Q2 2026, unchanged from $100,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
MBX Biosciences (MBX) Depreciation & Amortization (CF) (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, MBX Biosciences' Depreciation & Amortization (CF) came in at $348,000, up 1.2% year-over-year; for FY2025, it came in at $248,000, up 1.6% from FY2024.
- By year, Depreciation & Amortization (CF) came in at $244,000 in FY2024 (+22.0%) and $200,000 in FY2023.
- Year over year, Depreciation & Amortization (CF) gained in two of the last eight quarters, with growth averaging 8.7%.
- The high point for year-over-year Depreciation & Amortization (CF) in five years was Q1 2025 (growth of 108.3%); the low point was Q4 2024 (a decline of 47.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $100,000 (Q1 2026), $48,000 (Q4 2025) and $100,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 1.96 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 194.00 Mn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 599.00 Mn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 1.93 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 1.11 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 98.00 Mn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 1.62 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 56.50 Mn |
| 10 | MBX Biosciences | 2.57 Bn | 2.57 Bn | - | 100,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 100,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 48,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 44,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 48,000.00 |
| Dec 31, 2023 | 84,000.00 |
| Sep 30, 2023 | 100,000.00 |
API Access
MBX Biosciences Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=MBX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "MBX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=MBX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();